https://www.nytimes.com/2024/09/26/health/fda-schizophrenia-drug.html
F.D.A. Approves the First New Schizophrenia Drug in Decades
Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.